Mustang Bio MBIO
NASDAQ MBIO
$0.47 +0.00 (+0.58%)
As of: Oct 1, 2026 · 3:59 PM EDT

Mustang Bio (MBIO) Accumulated Depreciation (2023 - 2024)

Updated

Mustang Bio's Accumulated Depreciation came in at $5.15 million for Q4 2024, up 15.0% from $4.48 million a year earlier and up 1.0% from the prior quarter.

Analysis

Mustang Bio (MBIO) Accumulated Depreciation (2023 - 2024) Analysis & Trends

Going back to Q4 2023, Mustang Bio's Accumulated Depreciation data covers 4 quarters.

  • Going back by year, Accumulated Depreciation was $4.48 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Mustang Bio 3.10 Mn 3.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.15 Mn
Sep 30, 2024 5.10 Mn
Jun 30, 2024 5.05 Mn
Dec 31, 2023 4.48 Mn
API Access

Mustang Bio Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=MBIO&period=max&api_key=YOUR_API_KEY